medical treatment

APPEAL WATCH: If You Can’t Patent the Drug, Patent the Dosage

The Supreme Court of Canada (“SCC”) is set to review the patentability of dosage regimens for medical treatments. Last month, the SCC granted leave to appeal [41209] the Federal Court of Appeal (“FCA”) decision in Pharmascience Inc v Janssen Inc and Janssen Pharmaceutica NV, 2024 FCA 23 [FCA].

Rasouli’s consent required to withdraw life support, SCC rules

Mr. Rasouli has been in a persistent vegetative state at Sunnybrook Health Sciences Centre (“Sunnybrook”) since October 2010. For the past three years, he has been kept alive by way of mechanical ventilation and artificial nutrition and hydration. His doctors saw no prospect of recovery, and sought to withdraw Mr. Rasouli’s life support in order […]